医学
生物标志物
胰腺癌
化疗
肿瘤科
DNA测序
前瞻性队列研究
癌症
内科学
新辅助治疗
循环肿瘤DNA
DNA
癌症研究
遗传学
乳腺癌
生物
作者
Dhavan Shah,Amy Wells,M.C. Cox,Kevin Dawravoo,John Abad,Arlene D’Souza,Grace Suh,Robert Bayer,Sohail S. Chaudhry,Qiang Zhang,Massimo Cristofanilli,David J. Bentrem,Akhil Chawla
出处
期刊:Annals of Surgery
[Lippincott Williams & Wilkins]
日期:2024-01-23
卷期号:281 (6): 997-1005
被引量:13
标识
DOI:10.1097/sla.0000000000006209
摘要
This report demonstrates the prognostic value of ctDNA analysis with NGS in localized PDAC. NGS ctDNA is a biomarker of treatment response to NAC. KRAS ctDNA at diagnosis independently predicts worse survival in patients treated with NAC.
科研通智能强力驱动
Strongly Powered by AbleSci AI